Search

everythinglearnresearchcommunity

for

Search:↓

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

NK cells play a role in skin diseases like eczema and psoriasis.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.